Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942e9991d33292a8615f2d546ed430b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46b65993c75114bf9f710027d465c931 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2135217604c14b59fdd4c4353ee4163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2d3ce107406b896b38f01fef573742a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
filingDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1dc5812f8e7ec39d38d5b7aed019cb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6b7753cabd832e7942464d9de61cfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21d3010067beef5794fef2ce2c462e35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56ebd10c5b54d43640503a52983622f |
publicationDate |
2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009105641-A2 |
titleOfInvention |
Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
abstract |
The present invention is directed to a method of preventing or reducing amyloid deposition in a subject. This method involves selecting a subject with amyloid deposits and stimulating the innate immune system of the selected subject under conditions effective to reduce the amyloid deposits. Also disclosed is a method of preventing or treating cerebral amyloidosis and Alzheimer's Disease in a subject by administering to the selected subject an agent that stimulates the innate immune system. In addition, a composition useful for the stimulation of the innate immune system of a subject exhibiting symptoms associated with amyloid deposition is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015165961-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015185602-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874725-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013020722-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013020723-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013020724-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055981-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960019-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4209222-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015165968-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015165974-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9370531-B2 |
priorityDate |
2008-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |